Literature DB >> 6233012

Immunologic suppression after oral administration of antigen. III. Activation of suppressor-inducer cells in the Peyer's patches.

J A Mattingly.   

Abstract

Mice were orally administered sheep erythrocytes (SRBC) in a regimen previously known to produce systemic tolerance to SRBC. Cellular interactions and movement from the gut-associated lymphoid tissue (GALT) to the spleen were found to occur using both in vivo and in vitro transfer systems. The cell in the GALT which initiates the suppression circuit migrates from the GALT to the spleen shortly after contacting antigen. This cell is a T suppressor-inducer (Tsi) cell which interacts with splenic lymphocytes to induce the formation of an effector T suppressor cell (Ts). The Tsi and Ts can be separated from each other by their differential sensitivities to cyclophosphamide. In addition, the Tsi can be separated from other GALT T cells by its inability to bind the lectin, peanut agglutinin. Thus, cell migration and cellular interaction among T cells must occur to result in orally induced tolerance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233012     DOI: 10.1016/0008-8749(84)90357-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Distribution and functional characteristics of antigen-specific helper T cells arising after Peyer's patch immunization.

Authors:  M L Dunkley; A J Husband
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

2.  Development of bronchus associated lymphoid tissue (BALT) in human lung disease: a normal host defence mechanism awaiting therapeutic exploitation?

Authors:  P G Holt
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

3.  Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo.

Authors:  E O Gregg; L Yarwood; M J Wagstaffe; D S Pepper; M C Macdonald
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

4.  Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein.

Authors:  M F van den Broek; E J Hogervorst; M C Van Bruggen; W Van Eden; R van der Zee; W B van den Berg
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

5.  Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.

Authors:  Staley A Brod
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.